৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Products
Payment
Delivery
Composition
Empagliflozin 25 mg – an SGLT2 inhibitor
Linagliptin 5 mg – a DPP-4 inhibitor
Indications
Used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Helps reduce the risk of cardiovascular death and hospitalization for heart failure in patients with diabetes and established cardiovascular disease.
Mechanism of Action
Empagliflozin: Blocks SGLT2 in the kidneys, reducing glucose reabsorption and increasing urinary glucose excretion.
Linagliptin: Inhibits DPP-4 enzyme, increasing incretin hormones (GLP-1, GIP), which stimulate insulin release and reduce glucagon levels in a glucose-dependent manner.
Dosage & Administration
Typical dose: One tablet daily (25 mg Empagliflozin + 5 mg Linagliptin).
Must be taken as prescribed by a registered physician.
Not recommended for patients with type 1 diabetes or diabetic ketoacidosis.
Side Effects & Precautions
Common side effects: Urinary tract infections, increased urination, nasopharyngitis, cough, and headache.
Serious risks: Hypoglycemia (especially if combined with insulin or sulfonylureas), dehydration, ketoacidosis, and genital infections.
Precautions:
Monitor kidney function regularly.
Avoid in patients with severe renal impairment.
Use cautiously in elderly patients and those with cardiovascular disease.
N/A
N/A











